🔎 Trials Near Me

Home › Prostate Cancer › Georgia › Atlanta

Prostate Cancer clinical trials in Atlanta, GA

32 studies for Prostate Cancer are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.

Addressing Health Literacy With a Tailored Survivorship Care Plan

Recruiting
  • Grady Memorial Hospital, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • Atlanta VA Medical Center, Atlanta
Ages 18 and older · Men · Updated Sep 30, 2026 · NCT06674863

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RecruitingPhase 2
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

RecruitingPhase 1
  • Emory University Winship Cancer Institute, Atlanta
Ages 18 and older · Men · Updated Sep 28, 2026 · NCT06095089

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

RecruitingPhase 1
  • Emory Winship Cancer Institute, Atlanta
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07543055

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

RecruitingPhase 1
  • Emory University School of Medicine - Winship Cancer Institute, Atlanta
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07114601

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

RecruitingPhase 2
  • Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi away
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

RecruitingPhase 2
  • Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi away
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

RecruitingPhase 3
  • Emory University School of Medicine- Grady Campus ( Site 0103), Atlanta
  • Winship Cancer Institute, Emory University ( Site 0003), Atlanta
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RecruitingPhase 3
  • Grady Health System, Atlanta
  • Emory Proton Therapy Center, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • and 3 more
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

RecruitingPhase 3
  • Northside Hospital, Atlanta
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT06931340

Prostate Active Surveillance Study

RecruitingObservational study
  • Emory University, Atlanta
Ages 21 and older · Men · Updated Sep 2, 2026 · NCT00756665

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Atlanta VA Medical Center, Decatur · 6 mi away
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

RecruitingPhase 1
  • Emory University - Winship Cancer Institute, Atlanta
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06582017

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

RecruitingPhase 1
  • Emory University, Atlanta
Ages 18 and older · Men · Updated Aug 21, 2026 · NCT04221542

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

RecruitingPhase 1/2
  • Emory University Hospital, Atlanta
Ages 18 and older · Men · Updated Aug 20, 2026 · NCT06785636

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

RecruitingPhase 2
  • Winship Cancer Institute, Emory University, Atlanta
Ages 18 and older · Men · Updated Aug 17, 2026 · NCT06842498

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

RecruitingPhase 1/2
  • Emory University, Atlanta
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07288359

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

RecruitingPhase 3
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • and 3 more
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

RecruitingPhase 2
  • Emory University Hospital, Atlanta
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06865768

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

RecruitingObservational study
  • Morehouse School of Medicine, Atlanta
  • Emory Winship Cancer Institute, Atlanta
Ages 21 and older · Men · Updated May 22, 2026 · NCT03151629

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

RecruitingPhase 1/2
  • Emory University Hospital, Atlanta
Ages 18 and older · Men · Updated May 14, 2026 · NCT05413850

T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer

RecruitingPhase 2
  • Emory University, Atlanta
Ages 18 and older · Men · Updated Mar 4, 2026 · NCT05586360

REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

RecruitingPhase 3
  • Emory Proton Therapy Center, Atlanta
  • Winship at Emory Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • and 1 more
Ages 18 and older · Men · Updated Feb 24, 2026 · NCT06650579

Study of AZD0754 in Participants With Metastatic Prostate Cancer

RecruitingPhase 1/2
  • Research Site, Atlanta
Ages 18 to 130 · Men · Updated Feb 23, 2026 · NCT06267729

Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

Recruiting
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Ages 18 and older · Men · Updated Feb 17, 2026 · NCT04725903

Improving Health Literacy in African-American Prostate Cancer Patients

Recruiting
  • Atlanta VA Medical Center, Atlanta
  • Grady Memorial Hospital, Atlanta
  • Emory University, Atlanta
  • and 1 more
Ages 25 to 100 · Men · Updated Jan 29, 2026 · NCT03322891

Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients

RecruitingPhase 1/2
  • Emory University, Atlanta
Ages 18 to 90 · Men · Updated Dec 19, 2025 · NCT06262139

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

RecruitingPhase 1/2
  • Research Site 114, Atlanta
  • Research Site 139, Atlanta
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Atlanta
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

RecruitingPhase 3
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • and 2 more
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in Atlanta

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.